TY - JOUR
T1 - Olfactory function and alternation learning in eating disorders
AU - Stein, Daniel
AU - Gross-Isseroff, Ruth
AU - Besserglick, Roni
AU - Ziv, Amir
AU - Mayer, Gad
AU - Yaroslavsky, Amit
AU - Toledano, Anat
AU - Voet, Hillary
AU - Weizman, Abraham
AU - Hermesh, Haggai
PY - 2012/9
Y1 - 2012/9
N2 - Orbitofrontal dysfunction is a prominent feature of obsessive compulsive disorder (OCD). In the present study we assessed orbitofrontal functioning in eating disorders (EDs) which share many features with OCD. For this purpose we studied female adolescent inpatients with anorexia nervosa restricting type (n = 40), anorexia nervosa binge/purge type (n = 23), a normal weight group including patients with either bulimia nervosa or eating disorder not otherwise specified-purging type (n = 33), and 20 non-ED control females. Patients were assessed at admission, and when achieving weight restoration and symptom stabilization at discharge, for depression, non-ED, and ED-related OC symptoms. Orbitofrontal functioning was assessed with an alternation learning task, and with a battery assessing olfactory threshold and discrimination. Control females were assessed once. ED patients of all subtypes performed better on olfactory threshold and discrimination, but not on alternation learning, in comparison to healthy controls. More favorable orbitofrontal functioning was associated with greater ED-related obsessionality. No changes were found in olfactory threshold and discrimination between acutely-ill and symptomatically-stabilized patients. The improvement shown in alternation learning from admission to discharge was suggested to reflect a learning effect rather than being an actual change. Our findings suggest that the better orbitofrontal functioning of ED patients in comparison to healthy controls may represent a core feature of the ED that is independent of malnutrition and deranged eating behaviors, but is associated with ED-related obsessionality.
AB - Orbitofrontal dysfunction is a prominent feature of obsessive compulsive disorder (OCD). In the present study we assessed orbitofrontal functioning in eating disorders (EDs) which share many features with OCD. For this purpose we studied female adolescent inpatients with anorexia nervosa restricting type (n = 40), anorexia nervosa binge/purge type (n = 23), a normal weight group including patients with either bulimia nervosa or eating disorder not otherwise specified-purging type (n = 33), and 20 non-ED control females. Patients were assessed at admission, and when achieving weight restoration and symptom stabilization at discharge, for depression, non-ED, and ED-related OC symptoms. Orbitofrontal functioning was assessed with an alternation learning task, and with a battery assessing olfactory threshold and discrimination. Control females were assessed once. ED patients of all subtypes performed better on olfactory threshold and discrimination, but not on alternation learning, in comparison to healthy controls. More favorable orbitofrontal functioning was associated with greater ED-related obsessionality. No changes were found in olfactory threshold and discrimination between acutely-ill and symptomatically-stabilized patients. The improvement shown in alternation learning from admission to discharge was suggested to reflect a learning effect rather than being an actual change. Our findings suggest that the better orbitofrontal functioning of ED patients in comparison to healthy controls may represent a core feature of the ED that is independent of malnutrition and deranged eating behaviors, but is associated with ED-related obsessionality.
KW - Alternation learning
KW - Anorexia nervosa
KW - Bulimia nervosa
KW - Obsessive compulsive disorder
KW - Olfactory discrimination
KW - Orbitofrontal
UR - http://www.scopus.com/inward/record.url?scp=84865031264&partnerID=8YFLogxK
U2 - 10.1016/j.euroneuro.2011.12.006
DO - 10.1016/j.euroneuro.2011.12.006
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 22858418
AN - SCOPUS:84865031264
SN - 0924-977X
VL - 22
SP - 615
EP - 624
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
IS - 9
ER -